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Review Series: Immune Responses in the Host-Environment Interface - Understanding
the Mechanisms of Allergic Sensitization
Mucosal Immunity and the Onset of
Allergic Disease
Yusei Ohshima1
ABSTRACT
Mucosal barriers encounter an environment that is rich in pathogens that possess mechanisms for invading
mucosal tissues. These barriers also encounter innocuous antigens, such as foods, airborne antigens, and mi-
crobiota. The mucosa has developed a sophisticated immune system that can mount robust immune re-
sponses against pathogenic antigens, while maintaining mucosal tolerance against non-pathogenic antigens.
Accumulating evidence indicates that the mucosal epithelium, dendritic cells, and a subtype of T cells with
regulatory properties play important roles in the development and maintenance of mucosal tolerance. More-
over, the micribiota also contribute to regulating the mucosal immune system. A failure to develop or the break-
down of mucosal tolerance can result in allergic diseases, such as food allergy and asthma. By taking advan-
tage of the unique characteristics of the mucosal immune system, strategies that induce regulatory cells in vivo
and, thereby, reconstitute mucosal tolerance may be used to develop novel therapies that are suitable for treat-
ing or preventing of allergic diseases.
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INTRODUCTION
Because most pathogens enter the body through mu-
cosal surfaces, mucosal immune responses are re-
quired to ward off infection. These mucosal surfaces
are colonized by vast numbers of microbes, collec-
tively referred to as the microbiota. The microbiota
has been found to have profound effects on a host’s
immune system without provoking deleterious im-
mune responses.1 In addition, mucosal surfaces are
exposed to a wide variety of innocuous environmental
antigens, such as food in the intestine and aeroanti-
gens in the respiratory tracts. These innocuous anti-
gens can induce immune tolerance or hyporespon-
siveness rather than active immunity.
Mucosal tolerance prevents harmful inflammatory
responses, for example to food antigens, and plays a
role in establishing homeostasis between the micro-
biota and the host at mucosal membranes. Thus, mu-
cosal tolerance is not merely a lack of immune re-
sponse; rather, it is a specific immunological re-
sponse. A failure to develop or the breakdown of oral
tolerance can result in food allergy.2 This review will
describe recent findings that have contributed to our
understanding of the mechanisms of oral tolerance
and the pathophysiology of food allergy.
ORAL TOLERANCE IS PRIMARILY MEDI-
ATED BY REGULATORY T CELLS
In healthy adults, certain food proteins can be de-
tected in the blood soon after eating.3 These ingested
food proteins are not always ignored by the immune
system, because food antigen can simultaneously in-
duce the expression of an activation marker, CD69,
and behavioral changes in T cells in both local and
peripheral lymphoid tissues, depending on the anti-
gen doses.4,5
Weiner et al.6 demonstrated that the dose of a fed
antigen affected the mechanism underlying oral toler-
ance induction. Repeated exposure to low doses of
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antigen induced active suppression by several sub-
sets of regulatory T cells (Tregs), whereas exposure
to high antigen doses resulted in clonal deletion and
or anergy. We previously showed that active suppres-
sion by Tregs and clonal deletion andor anergy were
not mutually exclusive and that they may occur si-
multaneously after oral tolerance induction in Ag-
specific T cell receptor transgenic mice.7
Using an adoptive transfer system of Ag-specific T
cells, however, it has been demonstrated that Foxp3+
Tregs could be induced de novo from conventional na-
ive CD25−CD4+ T cells after tolerogenic Ag admini-
stration via the oral route in a dose-dependent fash-
ion.8 Moreover, there is little direct evidence that clo-
nal deletion andor anergy contributes to oral toler-
ance in the presence of a polyclonal T-cell repertoire.
These findings suggest that Tregs play a pivotal role
in the development of oral tolerance.
A number of different Tregs have been implicated
in oral tolerance, including IL-10-producing T-
regulatory type 1 cells (Tr1 cells) and TGF-β-
producing Th3 T cells, in addition to Foxp3+ Tregs.
Two main types of Foxp3+ Tregs have been identi-
fied. Natural Tregs (nTregs) are selected in the thy-
mus as a consequence of their reactivity to self,
whereas induced or adaptive Tregs (iTregs or
aTregs) develop in the peripheral immune system un-
der various conditions.9 Induction of the Foxp3+ pe-
ripherally derived Tregs (pTregs) from naïve T cells
requires TGF-β, which is produced by various cell
types, including Th3 CD4+ T cells. Although nTregs,
also referred to as thymus-derived Treg cells
(tTregs), are stable in vivo, iTregs can differentiate
into other types of effector T cells under inflamma-
tory conditions.10 In a mouse model in which iTregs
but not nTregs could be generated, oral tolerance
could not be induced, suggesting that iTregs were es-
sential for the development of oral tolerance.10,11
The common characteristics of Tregs are their ex-
pression of one or more anti-inflammatory cytokines,
such as IL-10, TGF-β, or IL-35, andor inhibitory sur-
face molecules, such as cytotoxic T-lymphocyte anti-
gen 4 (CTLA4), lymphocyte-activation gene-3 (LAG-
3), glucocorticoid-induced tumor necrosis factor re-
ceptor (GITR), CD39, CD73, or Nrp-1 (neurophilin
1).12-15
Oral tolerance is abolished in lymphotoxin-
deficient mice that lack both lymph nodes and
Peyer’s patches (PPs), but can be readily induced in
mice without PPs but with mesenteric lymph nodes
(MLNs).16 The initiation of oral tolerance is impeded
by mesenteric lymphadenectomy.17 MLNs appear to
be critical for inducing oral tolerance.
In contrast, it has been shown that injecting anti-
gen directly into the portal vein that drains blood
from the intestine to the liver induces antigen-specific
tolerance.18 Conversely, diverting the blood flow
away from the liver by portocaval shunting prevents
the induction of oral tolerance,19,20 indicating the in-
herent tolerogenicity of the liver. Kupffer cells, con-
ventional liver dendritic cells (DCs), and liver sinusoi-
dal endothelial cells, which efficiently sample circulat-
ing antigen and act as non-professional antigen-
presenting cells, have been shown to induce toler-
ance rather than active immunity.18 Moreover, plas-
macytoid DCs (pDCs), which have been implicated in
inducing systemic tolerance, are particularly abun-
dant in the liver.21 The relative contributions of
MLNs, the liver, and other sites to oral tolerance in-
duction remain unknown (Fig. 1).
A fraction of Tregs that expand in the lamina prop-
ria (LP) may exit this tissue and enter the circulation
either via the draining lymphatics, or directly via the
blood stream. Those iTregs that emigrate from the
LP may act more generally, either by directly inhibit-
ing systemic effector T cells or by promoting the gen-
eration of additional iTregs in systemic tissues by a
process of infectious tolerance.
INTESTINAL DENDRITIC CELLS ORGANIZE
INDUCTION AND EXPANSION OF iTregs
Two types of conventional CD11c+DCs (cDCs), such
as CD103 (αEβ7)+DCs and CD103−CX3CR1+ DCs
have been identified in the LP (2). Mucosal DCs can
capture antigen through at least four different routes.
CD103−CX3CR1+ DCs directly sample antigens by ex-
tending transepithelial dendrites between entero-
cytes. CD103+DCs can capture antigens that are
transported by paracellular diffusion across entero-
cytes that line the intestinal villus, either by a tran-
scellular transport mechanism, transcytosis by micro-
fold cells (M cells), or by goblet-cell-associated anti-
gen passage.22 To a certain extent, the routes of up-
take depend on the nature of the particular antigen.
Orally administered inert particles or nonpathogenic
bacteria appear to preferentially enter into gut associ-
ated lymphoid tissue (GALT) by M-cell-mediated
transcytosis, whereas soluble antigens are taken up
by DCs in the LP and, to a lesser extent, the GALT.23
Antigenic material may also reach the LP within
exosomes, which are formed by fusing major histo-
compatibility complex class II loading compartments
with endosomes that contain only partially degraded
proteins in enterocytes.23
The differentiation of CD103+DCs depends upon
retinoic acid (RA) and TGF-β produced by intestinal
epithelial cells.24 After acquiring antigen, CD103+DCs
migrate from the LP to the MLNs in a CCR7-
dependent manner.25 CD103+DCs express the en-
zyme retinaldehyde dehydrogenase (RALDH) 2,
which converts the vitamin A metabolite retinal to
RA. In concert with TGF-β, which is also produced by
CD103+DCs and is activated by the integrin αvβ8 on
these DCs, RA can promote the differentiation of
naïve T cells within the NLNs into Foxp3+
iTregs.14,26-29 CD103+DCs use RA to imprint naïve T
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Fig.　1　Roles of dendritic cells and mesenteric lymph nodes in oral tolerance. CX3CR1+ 
cDCs sample antigens by extending dendrites. CD103+DCs capture antigens that are 
transported by paracellular diffusion across enterocytes, either by M cell-mediated trans-
cytosis, or by goblet-cell-associated antigen passage. Antigen-loaded CD103+ cDCs mi-
grate to the mesenteric lymph nodes and then induce the differentiation of iTregs. 
CX3CR1+ cells produce IL-10 and facilitate the expansion of iTregs in the lamina propria. 
Antigen transported into the lamina propria may reach the liver via portal vein. Kupffer 
cells, cDCs, and sinusoidal endothelial cells act as non-professional antigen-presenting 
cells to induce tolerance.
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cells with the gut homing markers integrin α4β7 and
chemokine receptor CCR9. Further contributing to
their tolerogenic capabilities, CD103+DCs also ex-
press the enzyme indoleamine 2,3-dioxygenase
(IDO), which inhibits the generation of T-effector
cells by metabolizing tryptophan to kynurenine.30 In-
hibition of IDO was shown to abrogate the develop-
ment of Foxp3+iTregs in vitro and prevent the devel-
opment of oral tolerance in vivo.31 Removing vitamin
A andor tryptophan from the diet also hinders the
tolerogenic effects of CD103+DC by reducing their
ability to induce iTregs and imprint gut homing re-
ceptors on lymphocytes.30 Thus, CD103+DCs are es-
sential for oral tolerance induction.
In contrast, CD103−CX3CR1+CD11c+DCs are func-
tionally closer to macrophages than they are to cDCs,
as they do not migrate from the LP to MLNs and can-
not present antigen to naïve T cells under steady
state conditions.32 CD103−CX3CR1+ cells are efficient
at sampling antigens by extending transepithelical
dendrites and passing these antigens to neighboring
migratory CD103+DCs for subsequent transport and
presentation.23 CD103−CX3CR1+ cells have been
shown to produce IL-10 and locally facilitate the ex-
pansion of Foxp3+ iTregs in the LP.33 CD103−
CX3CR1+ cells are necessary for maintaining local tol-
erance induction, as tolerance is abrogated in CXCR1-
deficient mice.33
The transepithelial dendrites extended by
CX3CR1+ cells in the LP have been shown to interact
with bacteria in the lumen; thus, they may also play a
specific role in inducing tolerance to commensal bac-
teria. Recently, CX3CR1+CD11b+CD11c+ cells were
further subdivided into two subsets based on their ex-
pression levels of CX3CR1.34 CX3CR1intCD11b+
CD11c+ cells could promote the development of Th17
cells, whereas CX3CR1highCD11b+CD11c+ cells sup-
pressed CD4+ T-cell proliferation in a cell-cell contact-
dependent manner, and contributed to preventing in-
testinal inflammation.
pDCs can produce high levels of type I interferons,
and can also activate Foxp3+ iTreg as well as IL10+
Tr1 cells. A substantial proportion of MLN DCs pro-
duce CCL22, which attracts iTregs via CCR4, and are
located in juxtaposition to iTregs.35 The interaction
with iTregs via CTLA-4B7 may make DCs constitu-
tively express functional IDO. Mice that were geneti-
cally deficient in CCR4 showed markedly reduced
IDO expression in mesenteric lymph node DCs.
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INTESTINAL MUCOSA AND MESENTERIC
LYMPH NODES ENGENDER A TOLERO-
GENIC MILIEU
The acquisition of the unique tolerogenic properties
of CD103+DCs likely requires a specific milieu of lo-
cal conditioning factors provided by intestinal epithe-
lial cells (IECs), commensal bacteria, and dietary con-
stituents. IEC-derived factors may include TGF-β, RA,
IL-10, vasoactive intestinal peptide (VIP), thymic stro-
mal lymphopoetin (TSLP), and hepatocyte growth
factor (HGF).24,36-38 The sources of RA in the intes-
tine may include RA produced by epithelial cells,
which metabolize retinoids taken up from the diet.39
Intestinal epithelial cell-derived RA induces DCs to
express RALDH, and thereby intestinal DCs are capa-
ble of metabolizing food-derived vitamin A to produce
RA by themselves.38 Independent of tolerogenic DCs,
epithelial cells express MHC class II molecules, but
not conventional co-stimulatory molecules; thus, that
they may act as nonprofessional APCs to induce T
cell anergy.40
Stromal cells from mesenteric lymph nodes also
express higher levels of RA-producing enzymes than
do peripheral lymph node stromal cells.41 Stromal
cells from mesenteric lymph nodes, but not from
skin-draining lymph nodes, support the generation of
Foxp3+ Tregs. This suggests that tissue-specific dif-
ferences in stroma may also aid in generating a
uniquely tolerogenic milieu.
CD8+ T CELLS AND γδ T CELLS ALSO
FUNCTION AS REGULATORY CELLS IN
MUCOSAL IMMUNITY
Accumulating evidence has shown that subsets of
CD8+ T-cells function as regulatory cells either di-
rectly by killing immune cells or indirectly by coopt-
ing other cells to produce suppressive molecules,
such as TGF-β and IL-10.42,43 Although LP CD8+ T
cells and intestinal epithelial cell-activated CD103+
CD8+ T cells exhibit regulatory activities in vitro and,
thus, might play an active role in oral tolerance,44,45
the role of these CD8+ T cells in controlling allergic
reactions in the gastrointestinal mucosa remains un-
certain. We have demonstrated that systemic immu-
nization with allergen induced regulatory CD8+ T
cells that could inhibit the development of allergic di-
arrhea and that these CD8+ T cells may have exerted
a regulatory function through both IL-10-dependent
and -independent mechanisms.46 These findings sug-
gest the possibility that manipulating CD8+ regula-
tory T cells may expand our therapeutic strategies for
food allergy.
In a food allergy mouse model, γδ TCR blockade
prior to inducing sensitization resulted in higher
antigen-specific IgE levels and incrased mast cell de-
granulation. These findings suggest a regulatory role
for γδ T cells in the development of allergic sensitiza-
tion.47 A possible role for natural killer T (NKT) cells
in oral tolerance is controversial and the outcomes
may depend on the experimental models used. NKT
cell-deficient mice showed impaired oral tolerance
due to a failure to induce IL-10 and TFG-β producing
CD25+CD4+ Tregs.48 Oral tolerance was normally in-
duced in Jα281−− mice that lacked Vα14+ NKT cells,
suggesting that NKT cells are dispensable for induc-
ing oral tolerance.49
REGULATORY B CELLS CAN INDUCE
Tregs
Emerging evidence suggests that regulatory types of
B cells (Bregs) that are generated under inflamma-
tory conditions are capable of inducing tolerance.
Bregs may comprise several subpopulations that ex-
hibit different mechanisms of immunomodulation, in-
cluding the production of anti-inflammatory cytokines
(IL-10 or TGF-β1), functioning as inhibitory antigen
presenting cells, and inducing or recruiting Tregs.50
Mouse IL-10-producing B cells (designated B10 cells)
display the CD1dhiCD5+CD19hi phenotype and sup-
press allergic inflammation through their induction of
iTreg cells.51 B cells isolated from Peyer’s patches
can generate iTregs that express CTLA4, ICOS,
OX40, PD-1, and TNF-RII, and produce lower
amounts of IL-2 and higher amounts of IL-10.52 B
cells in Peyer’s patches may play an important role in
oral tolerance as regulatory cells.
In humans, B10 cells have been identified within
the CD24hiCD27+ B cell compartment and negatively
regulate monocyte cytokine production in an IL-10-
dependent manner.53 Although B10 cells represent a
small fraction of blood B cells in healthy subjects,
they are increased in the blood of patients with in-
flammatory disorders.53 Recent evidence has impli-
cated regulatory B cells in the development of toler-
ance to food allergens in humans; however, it re-
mains unknown how these cells are related to human
B10 cells.54,55
IgA PROTECTS AGAINST SENSITIZATION
OR TRIGGERING OF ALLERGIC REAC-
TIONS BY ORAL ANTIGENS
Foxp3+CD4+ Treg cells in Peyer’s patches can differ-
entiate into follicular B helper T cells (TFH cells),
which then participate in immunoglobulin A re-
sponses against intestinal antigens.56 Secretary IgA
(sIgA), a prototypic mucosal immunoglobulin, pre-
vents the uptake of antigens from the gut lumen and
also secrets back out antigens that have penetrated
the epithelial barrier into the lumen by forming sIgA-
antigen complexes. IgA deficiency in children has
been reported to be associated with an increased fre-
quency of food allergy.57 Thus, IgA has been hy-
pothesized to play a protective role in the context of
food allergy.
However, Strait et al. found that systemic transfer
Mucosal Immunity
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of antigen-specific IgA was also protective against
anaphylaxis that was triggered by the oral route.58
However, this was not dependent on IgA secretion
into the lumen, and IgA had no protective effect when
it was administered in conjunction with the antigen
intraluminally, suggesting that IgA has protective ef-
fects at the systemic level but do not rule out a pro-
tective role for IgA at the mucosal surface.
In contrast to the immune exclusion by sIgA, sIgA-
antigen complexes are transported by M cells from
the intestinal lumen to subepithelial DCs, which rec-
ognize and internalize these complexes through the
C-type lectin DC-SIGN on DCs.59 Antigen presented
in conjunction with IgA generates a different type of
immune response than that when antigen is pre-
sented alone. Antigen-specific and total IgA levels in
maternal milk were found to be significantly lower in
mothers whose children developed cow’s milk al-
lergy, indicating that IgA may play a critical role in
preventing early sensitization to food allergens.60
Sublingual immunotherapy with peanut antigens
for treating peanut allergy in humans resulted in in-
creased peanut-specific IgA levels in saliva, and these
IgA levels were correlated with the degree of clinical
protection.61 These results support the concept that
antigen-specific IgA is protective against primary sen-
sitization or triggering of allergic reactions by food
antigens.
COMMENSAL BACTERIA AFFECT THE DE-
VELOPMENT AND MAINTENANCE OF
ORAL TOLERANCE
The intestinal microbiota is beneficial for a host, as
they aid in digestion, provide protection against
pathogens, and induce and maintain immune system
suitability. Conversely, the host can actively control
the steady state composition of the microbiota by se-
creting antimicrobial peptides and immunoglobulins,
which highlights the state of a highly active dynamic
symbiosis.62 The microbiota tightly controls constitu-
tive cytokine production by lymphocytes, as germ-
free mice exhibit considerable deficiencies in basal
cytokine production.63,64 Specific commensals can
shape the gut-associated immune system. For exam-
ple, segmented filamentous bacteria (SFBs) and Clos-
tridium spp. regulate the prevalence of distinct helper
and regulatory T cell populations.65,66 Commensal
bacteria, such as Bacteroides and Bifidobacteria spp,
can directly induce monocyte-derived DCs to acquire
a tolerogenic phenotype.67 The microbiota can also
directly contribute to the expansion of LP resident
CX3CR1+ cells, which is associated with local expan-
sion of Treg cells.68 Microbiota-derived products can
also control the activation status of liver resident DCs
and increase the activation threshold required for in-
ducing of immune responses.69 Thus, it is conceiv-
able that the composition of microbiota might affect
oral tolerance.
There are controversial reports on the capacity to
induce oral tolerance in germ-free mice that are de-
void of live intestinal bacteria.70,71 In the absence of a
microbiota, the CD4+ T cell population is diminished
and disproportionately affects the production of Th1
and Th17 cells, although Treg frequencies are main-
tained or increased in the small intestine.63 Coloniza-
tion of germ-free mice with complex microbiota or-
chestrates a broad spectrum of Th1, Th17 and Treg
responses.72 Oral tolerance can be restored by recon-
stituting germ free mice with Bifidobacterium infan-
tis, a dominant commensal bacterium or by feeding
these mice with LPS.73,74 Although LPS has been as-
sociated with the acquisition of oral tolerance, the
precise molecular mechanisms underlying this phe-
nomenon and the targets of microbe-derived signals
remains incompletely understood. Moreover, in a
mouse model, feeding them with Clostridium leptum
increased the number of Tregs in the spleens, and
mediastinal lymph nodes, and attenuated allergen-
induced airway hyperresponsiveness and inflamma-
tion by inhibiting inflammatory cytokine production,
while enhancing IL-10 and TGF-β1 production in the
lungs.75
After the hygiene hypothesis was first proposed,
some epidemiological data suggested that asthma
and atopic diseases were associated with childhood
antibiotic use and an altered intestinal microbiota and
that the compositions of the intestinal microbiota dif-
fered between allergic and nonallergic infants.76,77 A
birth cohort study that followed high-risk children
from birth to 6 years of age demonstrated that the
bacterial diversity in the intestinal microbiota was in-
versely associated with the risk of allergic sensitiza-
tion to foods and aeroallergens, peripheral blood
eosinophilia, and allergic rhinitis.78 Other studies
have identified specific differences in the microbiota
of allergic and nonallergic children.79,80
To date, no definitive subset of the microbiota has
been identified that is associated with atopy, aside
from limited evidence that Clostridium difficile may
be overrepresented in some atopic infants.81 This
suggests that although intestinal microbial coloniza-
tion is required for proper immune function develop-
ment, certain types of microbes may play a significant
role in skewing immune responses toward allergic
sensitization, possibly by creating an environment
that enhances the development of allergic disease.
ORAL ANTIGEN SENSITIZATION AND THE
DEVELOPMENT OF FOOD ALLERGY
Food allergies develop in genetically predisposed in-
dividuals, presumably when oral tolerance fails to de-
velop normally or when it breaks down. The mecha-
nisms underlying allergic sensitization to food anti-
gens remain elusive. Roth-Walter et al. reported that
the soluble whey proteins α- and β-lactalbumin were
readily transcytosed through enterocytes, whereas
Ohshima Y
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insoluble casein in micelles and heat-aggregated α-
and β-lactalbumin were preferentially taken up into
Peyer’s patches.82 The delivery of food antigens into
the Peyer’s patches may have resulted in a more ro-
bust sensitization. However, if these antigens were
unable to traffic across the villus enterocytes, they
were unable to elicit anaphylactic symptoms upon
oral challenge. These results suggest that for the de-
velopment of food allergy, both antigen sensitization
established by antigen uptake via Peyer’s patches and
exposure to ample amounts of soluble antigens that
are transferred across the epithelial barrier are indis-
pensable.
Human intestinal epithelial cells constitutively ex-
press the low affinity IgE receptor CD23 and,
thereby, transport IgE from both the basal-to-apical
and apical-to-basal directions.83 Antigen-IgE com-
plexes were preferentially transported in the apical-to-
basal direction and were released into the basolateral
media in a form that could stimulate FcεRI receptor.83
Therefore, it is possible that the presence of antigen-
specific IgE can increase the amounts of transported
antigens across the epithelium.
PULMONARY DENDRITIC CELLS DICTATE
MUCOSAL TOLERANCE AND Th2 IMMU-
NITY
A network of CD11b− cDCs that express CD103,
langerin, and increased lymphotactin receptor XCR1,
is found in the epithelial layer of the conducting air-
ways. These cells protrude cellular extensions be-
tween the basolateral spaces of basal epithelial cells.
Immediately below the basement membrane, the
lamina propria contains CD11bhi cDCs that express
SIRPα, and increased levels of the fractalkine recep-
tor CX3CR1. The conducting airways also contain
CD11cdim pDCs that express Siglec-H and bone mar-
row stromal antigen-2 (BST2).84
Lung parenchymal DCs are found in the alveolar
septa. These can also be subdivided into CD11b+ and
CD11b−cDCs, and include a subpopulation of pDCs.
Some DCs, primarily CX3CR1+CD11b+ cells, also pa-
trol the vessel walls of the pulmonary arterial vascula-
ture and can capture injected embolic material.84
During inflammation, additional CD11b+ monocyte-
derived DCs that express Ly6C and FcεRI are re-
cruited to the lungs. In human bronchoalveolar lav-
age (BAL) fluid, three types of DC populations have
been identified; CD11c+CD1c+ myeloid (m)DC type
1, CD11c+BDCA-3 (CD141)+ mDC type 2, and
CD11c−BDCA-2+ pDCs. Human mDC1s correspond
to the mouse CD11b+CD103− cDC subset, mDC2s
correspond to CD11b−CD103+langerin+ cDCs, and
human pDCs correspond to murine pDCs.84
Mouse intraepithelial lung CD103+CD11b− cDCs
and human monocyte-derived DCs form tight junc-
tions with neighboring airway epithelial cells to pro-
tect the epithelial barrier function during the proc-
esses involved with antigen uptake, while allowing
the exchange of inhaled particles. The transepithelial
transport of inhaled antigens by CD103+CD11b−
cDCs is followed by antigen uptake by more deeply
situated CD11b+ cDCs. These lung DCs orchestrate
the immune responses to pathogens, commensal bac-
teria and innocuous inhaled antigens.85 Whether a
specific subset of DCs presents inhaled antigens in a
tolerogenic manner or induces Th2-biased immune
responses remains unknown.
Pulmonary DCs survey the airways by continu-
ously migrating from the lungs to the T cell paracor-
tex of the draining mediastinal and peribronchial
lymph nodes in a CCR7-dependent way.86,87 Those
DCs that concomitantly acquire a semi-mature pheno-
type by receiving subtle maturation signals, presum-
ably from the local microbiota, are thought to induce
Tregs that control pulmonary tolerance and homeo-
stasis.11,88-90 Quiescent pulmonary stromal cells pro-
mote TGF-β-dependent differentiation of tolerogenic
DCs, which promote the differentiation of Tregs in vi-
tro.91
Three pDCs subsets can be identified based on
their expressions of CD8α and CD8β, and exhibit dif-
ferences in their functional capacities to prime naïve
CD4+ T cells. CD8α−β− pDCs are immunogenic,
whereas CD8α+β− and CD8α+β+ pDCs exhibit tolero-
genic properties to support the conversion of naive
CD4+ T cells into Foxp3+ Treg cells.92 Expression of
RALDH1, 2 and 3 by tolerogenic lung pDCs and the
subsequent production of RA are critical for inducing
Treg cells.14,92 The steady state co-existence of cDCs
with pDCs is thought to promote tolerance to inhaled
antigens.
When there is concomitant exposure to innocuous
antigens with inhaled environmental adjuvants, such
as cigarette smoke, fine particulate matter, or bacte-
rial contaminants, lung DCs acquire appropriate
maturation stimuli, and subsequently release cytoki-
nes and express costimulatory molecules that govern
acquired immunity. A subset of c-kit+ FcεRI+ DCs or
SIRPα+CD11b+ DCs has been shown to effectively
prime Th2-biased immunity.93-96 It was recently
shown that CD11b+ cDCs, but not CD103+ cDCs,
were primarily responsible for inducing Th2 immu-
nity in HDM-specific T cells and that monocyte-
derived DCs were also sufficient to induce Th2 cell-
mediated immunity, but only when high-dose HDM
was administered.97 Moreover, in allergen-challenged
mice, CD11b+ DCs were a prominent source of the
chemokines CCL17 and CCL22, and thereby re-
cruited CCR4+ Th2 cells to the lungs.98,99 Although
any lung DCs appear to have the capacity to induce
Th2 effector responses, as well as Th1, or Th17 re-
sponses, depending on the type and strength of the
provoking stimulus, a subset of DCs may play critical
roles during the priming and maintenance of Th2 im-
munity and antigen sensitization.
Mucosal Immunity
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PULMONARY EPITHELIUM INITIATES ANTI-
GEN SENSITIZATION
The pulmonary epithelium provides a barrier be-
tween the external inhaled environment and the in-
ternal tissues. Besides providing a physical barrier,
the pulmonary epithelium is immunologically active
and is pivotal in the development of immune re-
sponses in the lung. Pulmonary epithelial cells can
secrete a wide range of cytokines and chemokines in
response to danger signals and, thereby, direct im-
mune responses and recruit cells of the innate and
adaptive immune system.
Epithelial cells sense microbes through pattern
recognition receptors (PRRs) that include TLRs,
NOD-like receptors, protease-activated receptors
(PARs), and C-type lectin receptors, which recognize
pathogen-associated molecular patterns from viruses,
bacteria, fungi, and multicellular parasites.100 Al-
though PRR-triggered immune responses provide a
critical antimicrobial monitoring system, it is now
clear that many allergens have the potential to modify
the epithelial barrier through PRRs. CD23 ligation
can activate pro-inflammatory pathways in human in-
testinal epithelial cells and result in the release of
chemokines, including CCL20.101
Bronchial epithelial cells first attract immature DCs
or their precursors through their release of CCL2 or
CCL20 chemokines and subsequently instruct them
to induce Th2 immunity to allergens via the release of
innate pro-Th2 cytokines, such as GM-CSF, thymic
stromal lymphopoietin (TSLP), and IL-25 and
-33.102,103 IL-33 and TSLP can drive allergic inflamma-
tion, even in the absence of IL-4, and promote Th2
cell differentiation by programming the function of
DCs.104-106 IL-25 exacerbates airway hyperreactivity
in the absence of Th2 cytokines.107
House dust mite antigen triggers epithelial cells to
produce IL-1α in a TLR4-dependent manner.108 The
IL-1α subsequently acts in an autocrine manner on
the lung epithelial cells, which results in their secre-
tion of proinflammatory chemokines, GM-CSF, and
IL-33. Together, these mediators recruit and activate
inflammatory DCs that induce adaptive Th2 immunity
to this antigen. TSLP becames important only when
high doses of antigen are administered.
APPLICATION OF MUCOSAL IMMUNITY TO
IMMUNOTHERAPY FOR ALLERGIC DIS-
EASES
Mucosal immunotherapy is more advantageous com-
pared with subcutaneous immunotherapy from a pro-
duction and regulatory perspective; antigens that are
used for mucosal immunotherapy do not require ex-
tensive purification to remove bacterial contaminants,
as the mucosal surface is already colonized by bacte-
ria. The procedure for antigen administration is rela-
tively easy. Under normal conditions, however, after
their ingestion, proteins or carbohydrates are ex-
posed to changing pH levels and digestive enzymes
during gastrointestinal transit, resulting in antigen
degradation.109
The capacity of transcytosis through the intestinal
epithelial layer depends on particle size; a particle
size <1 μm is optimal for M-cell absorption.110 Tran-
scytosis also depends on the charge and hydrophilic-
ity of the particle carrier. Once bound to the apical
side of M cells, macromolecules are endocytosed via
clathrin-coated vesicles, and thereby reach the ly-
sosomal compartment, from which they are exocyto-
sed to a basolateral site to be taken up by DCs. To
overcome the degrading conditions in the gastroin-
testinal tract, encapsulating antigens into particle car-
riers, such as liposomes may enable intact antigens to
reach the intestinal epithelial layer.111 Furthermore,
modifying particles by special targeting materials can
direct particle binding to specific cells and enhance
the particle uptake capacity via intestinal cells and
DCs.
Several studies have demonstrated that mannosyla-
ted-liposomes could enhance both Ag presentation
and T cell stimulation by targeting mannose recep-
tors on APCs.112-114 The combination of a dimannosyl
ligand for liposomal vesicle targeting and Toll-like re-
ceptor (TLR)-2 ligand Pam2CAG for immune stimula-
tion promoted binding to APCs and stimulating cellu-
lar immune responses.115 Subcutaneous or intraperi-
toneal delivery of oligomannose-coated liposomes in-
duced only systemic immune responses, whereas in-
tranasal delivery induced mucosal immunity as well
as systemic immunity.116 Therefore, the modifica-
tions used for antigen particle carriers and the route
of administration are important determinants for the
effects of immunotherapy.
Zhou et al. reported that sugar modified antigen
binding to the innate immune receptor SIGN-R1
(murine homolog of human DC-SIGN) could reduce
the anaphylactic response to food allergen by induc-
ing DCs to release IL-10 and to generate Tr1 cells.117
Based on their findings, we have demonstrated that
intranasal immunization with Ag encased in oligo-
mannose coated liposomes may be an effective immu-
notherapy for food allergies, as it induced a subset of
regulatory CD8+ T cells as well as CD4+CD25+Foxp3+
T cells and modulated humoral immune responses,
even in allergen-sensitized mice.118
CONCLUSION
We have focused primarily on DCs and various regu-
latory cells that may participate in the induction of
oral tolerance and the mechanisms that have been
elucidated primarily in animal models. Understand-
ing the mechanisms involved in oral tolerance is cru-
cial for the development of novel therapeutic strate-
gies to prevent or reverse hypersensitivity reactions
to foods and aeroantigens.
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